Isofol Medical

Market Cap 881.5M

Isofol Medical is a Swedish biotech company developing Modufolin, a new folate-based therapy used in the treatment of colorectal cancer and as a rescue therapy after high-dose chemotherapy treatment. The company was founded in 2008 through a collaboration between Professor Bengt Gustavsson and Merck & Cie. Isofol Medical is based in Gothenburg and is listed at First North Premier since April 2017.

+ more

Community Posts

Be the first to write something about this company in the community.

Create new post